Clarus Therapeutics Holdings, Inc.·4

Dec 14, 7:00 PM ET

Hernandez Joseph 4

4 · Clarus Therapeutics Holdings, Inc. · Filed Dec 14, 2021

Insider Transaction Report

Form 4
Period: 2021-12-12
Transactions
  • Award

    Common Stock

    2021-12-12+3,8443,844 total
  • Award

    Stock Option (Right to Buy)

    2021-12-12+9,6109,610 total
    Exercise: $4.78Exp: 2031-12-11Common Stock (9,610 underlying)
Holdings
  • Common Stock

    (indirect: See Footnote)
    1,302,500
Footnotes (3)
  • [F1]The Reporting Person was granted a Restricted Stock Unit under the Issuer's 2021 Stock Option and Incentive Plan (the "2021 Plan") for 3,844 shares on 12/12/2021, which vests in equal annual installments over three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting date.
  • [F2]Mr. Joseph Hernandez, a director and former chief executive officer of the Issuer, is the managing member of the Blue Water Sponsor LLC (the "Sponsor"). Accordingly, Mr. Hernandez may be deemed to have beneficial ownership of such shares. Mr. Hernandez disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest he may have therein, directly or indirectly.
  • [F3]These options were granted under the 2021 Plan and vest in equal annual installments over a period of three years from the date of grant subject to the Reporting Person having a service relationship as of each such vesting.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION